Mikhaila Rice

5PUBLICATIONS
24CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

|Apr 29, 2025
Development of an Endothelial Activation and Stress Index (EASIX)-based predictive model for cytokine release syndrome and neurotoxicity after B-cell maturation antigen directed chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma.

Utkarsh Goel, Danai Dima, James A Davis

|Mar 04, 2025
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.

James A Davis, Jordan Snyder, Mikhaila Rice

|Nov 05, 2023
Development and validation of a model to predict acute kidney injury following high-dose methotrexate in patients with lymphoma.

Mikhaila L Rice, Erin F Barreto, Andrew D Rule

|Jun 22, 2021
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.

Mikhaila L Rice, Jason N Barreto, Carrie A Thompson

Pageof 1

Frequent Collaborators

3 joint publications

Jack Khouri

2 joint publications

Jason N Barreto

2 joint publications

Carrie A Thompson

2 joint publications

Kristin C Mara